Microrna Market Size, Share & Trends Analysis Report 2021-2028
microRNA Industry Overview
The global microRNA market size was valued at USD 854.6 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 19.8% from 2021 to 2028. Key trends that have collectively contributed to market growth over the years include emerging microRNA (miRNA) tools for disease-associated analytical applications, immense traction gained by miRNA target prediction and identification, and persisting wide adoption of the majority of the miRNA tools. Additionally, miRNAs are amongst the most important potential biopharmaceutical candidates that are entering in commercial space for developing potential future medicines.
Biopharmaceutical companies are increasingly engaging in the search for new therapeutic molecules that can act as new drugs which is further driving the market for microRNA. There are several miRNA-based candidates that are under clinical trials such as anti-miR compounds and specific inhibitors for miRNAs which can act as potential therapeutic solutions. Hence, RNA therapeutics is considered a trending investing area that will lead to the development of profitable drugs.
Gather more insights about the market drivers, restrains and growth of the Global microRNA market
Increasing adoption of microRNA as a biomarker is driving the market. The miRNA biomarkers are of particular focus on genome-wide studies, and data-driven methodology, as they demonstrate high reproducibility and robustness when compared to traditional methods. Hence, they serve as promising candidates for the development of biomarkers. Moreover, the growing interest in liquid biopsies has further led to the increasing importance of miRNAs for biomarker discovery and development.
A steep increase in the research activities exploring the potential of miRNA biomarkers across prognosis, diagnosis, and therapeutics is expected to favor the market expansion in the near future. For instance, in January 2020, researchers explored the possibility of miRNA found in peripheral blood as a biomarker for diagnosing Bipolar II disorder (BD-II) using next-generation sequencing. miRNAs can be a possible noninvasive solution for the diagnosis of other neurodegenerative disorders.
In addition, the technological innovation for improving the sensitivity and selectivity of miRNA detection is further contributing to the growth of the market for microRNA. The newly developed methods for miRNA detection include nanoparticle-based amplification, RCA-based methods, DSN-based methods, LAMP-based methods, and enzyme-free amplification. Similarly, in January 2020, researchers developed a program-based isothermal amplification technique for specific and quantitative digital measurement of miRNA. The advantage of the system is that contamination is reduced by the fact that this system is dependent on the signal amplification process rather than direct replication of the targeted sequence, as it is done using PCR-based approaches.
Browse through Grand View Research's Biotechnology Industry Research Reports.
- Healthcare Specialty Enzymes Market - The global healthcare specialty enzymes market size was valued at USD 2.4 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2020 to 2027. The rising prevalence of diseases associated with metabolism has been witnessed in recent years wherein an appropriate understanding of enzyme abnormality has led to the increasing use of enzymes as disease markers in clinical examinations.
- DNA Sequencing Market - The global DNA sequencing market size was valued at USD 4.7 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2020 to 2027. Rapid advancements in sequencing technology and bioinformatics have enabled the identification of DNA variations. These advancements also determine variants associated with increased risk for disease.
microRNA Market Segmentation
Grand View Research has segmented the global microRNA market on the basis of products, services, application, end-use, and region:
microRNA Products Outlook (Revenue, USD Million, 2017 - 2028)
- Instruments
- Consumables
microRNA Services Outlook (Revenue, USD Million, 2017 - 2028)
- Service Type
- By Specimen
microRNA Application Outlook (Revenue, USD Million, 2017 - 2028)
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
microRNA End-use Outlook (Revenue, USD Million, 2017 - 2028)
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Other end-users
microRNA Regional Outlook (Revenue, USD Million, 2017 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Market Share Insights
- July 2020: Sistemic Ltd announced the expansion of its patent covering for the use of microRNAs as predictive analytes for cellular function.
Key Companies profiled:
Some prominent players in the global microRNA market include
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- Horizon Discovery Ltd.
- Synlogic
- QIAGEN
- GeneCopoeia, Inc.
- New England Biolabs
- Quantabio
- NanoString
- BioGenex
- SeqMatic LLC
- Miltenyi Biotec
- Sistemic Scotland Limited
- Biodynamics Laboratory Inc.
- OriGene Technologies, Inc.
Order a free sample PDF of the microRNA Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment